In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 5-Bromonicotinic acid 10-methoxy-1,6-dimethylergoline-8-methyl ester Drug Master File in Korea (5-Bromonicotinic acid 10-methoxy-1,6-dimethylergoline-8-methyl ester KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 5-Bromonicotinic acid 10-methoxy-1,6-dimethylergoline-8-methyl ester. The MFDS reviews the 5-Bromonicotinic acid 10-methoxy-1,6-dimethylergoline-8-methyl ester KDMF as part of the drug registration process and uses the information provided in the 5-Bromonicotinic acid 10-methoxy-1,6-dimethylergoline-8-methyl ester KDMF to evaluate the safety and efficacy of the drug.
After submitting a 5-Bromonicotinic acid 10-methoxy-1,6-dimethylergoline-8-methyl ester KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 5-Bromonicotinic acid 10-methoxy-1,6-dimethylergoline-8-methyl ester API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 5-Bromonicotinic acid 10-methoxy-1,6-dimethylergoline-8-methyl ester suppliers with KDMF on PharmaCompass.